StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

4-Methylmorpholine → (1R,10R,11S,16S)-3-hydroxy-1,11,15,15-tetramethyl-5-[(morpholin-4-yl)-carbonyl]-8lambda6-thiatetracyclo[8.8.0.02,7.011,16]-octadeca-2,4,6-triene-8,8-dione

HRID 422177
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 422177
C[O:2][C:3]1[CH:20]=[C:19]([C:21]([OH:23])=O)[CH:18]=[C:17]2[C:4]=1[C@H:5]1[C@H:14]([CH2:15][S:16]2(=[O:25])=[O:24])[C@:13]2([CH3:26])[C@H:8]([C:9]([CH3:28])([CH3:27])[CH2:10][CH2:11][CH2:12]2)[CH2:7][CH2:6]1.[CH3:29]N(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN1CCOCC1.[NH:60]1[CH2:65][CH2:64][O:63][CH2:62][CH2:61]1>C1COCC1.CN(C=O)C>[OH:2][C:3]1[CH:20]=[C:19]([C:21]([N:60]2[CH2:65][CH2:64][O:63][CH2:62][CH2:61]2)=[O:23])[CH:18]=[C:17]2[C:4]=1[C@@:5]1([CH3:29])[C@H:14]([CH2:15][S:16]2(=[O:24])=[O:25])[C@:13]2([CH3:26])[C@H:8]([C:9]([CH3:28])([CH3:27])[CH2:10][CH2:11][CH2:12]2)[CH2:7][CH2:6]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 79724-MethylmorpholineHCID 8083MorpholineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 86654189(1R,10S,11S,16S)-3-methoxy-11,15,15-trimethyl-8,8-dioxo-8lambda6-thiatetracyclo[8.8.0.02,7.011,16]octadeca-2,4,6-triene-5-carboxylic acid

Produkt 1

HCID 53240756
(1R,10R,11S,16S)-3-hydroxy-1,11,15,15-tetramethyl-5-[(morpholin-4-yl)-carbonyl]-8lambda6-thiatetracyclo[8.8.0.02,7.011,16]-octadeca-2,4,6-triene-8,8-dione
Ausbeute 54 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittelHCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

A mixture of (1R,10S,11S,16S)-3-methoxy-11,15,15-trimethyl-8,8-dioxo-8λ6-thiatetracyclo[8.8.0.02,7.011,16]octadeca-2,4,6-triene-5-carboxylic acid (61) (0.08 g, 0.2 mmol), HATU (0.15 g, 0.40 mmol), N-methylmorpholine (0.04 mL, 0.6 mmol) and morpholine (0.086 mL, 1.0 mmol) in THF (4.0 mL) and DMF (1.0 mL) was stirred at room temperature for 18 h. The THF was evaporated under reduced pressure, the residue was quenched with water and the resulting solid was collected by filtration. The crude product was purified by flash column chromatography on silica gel (Hexanes/EtOAc, 3:1) to give (1R,10R,11S,16S)-3-hydroxy-1,11,15,15-tetramethyl-5-[(morpholin-4-yl)-carbonyl]-8λ6-thiatetracyclo[8.8.0.02,7.011,16]-octadeca-2,4,6-triene-8,8-dione (87) (0.05 g, 54%) as a white solid. 1H NMR (DMSO-d6): δ 7.18 (d, 1H), 7.00 (d, 1H), 3.70-3.24 (m, 10H), 1.90 (d, 1H), 1.83 (d, 1H), 1.70-1.32 (m, 8H), 1.28-1.08 (m, 3H), 0.97 (d, 1H), 0.92 (s, 3H), 0.85 (m, 4H), 0.81 (s, 3H). MS m/z 476 (C26H37NO5S+H+).

Aufarbeitung

  1. customThe THF was evaporated under reduced pressure
  2. customthe residue was quenched with water
  3. filtrationthe resulting solid was collected by filtration
  4. customThe crude product was purified by flash column chromatography on silica gel (Hexanes/EtOAc, 3:1)

Quellen und Nachweise

ORD-Eintrag
ord-bd84ffa557be4a46864c2e822563e0ff
Quelldatensatz
uspto-grants-2012_01
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08101605B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion